.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Chinese Patent Office
Moodys
Deloitte
Dow
Chubb
Fuji
Covington
Argus Health

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,300,291

« Back to Dashboard

Summary for Patent: 5,300,291

Title: Method and device for the release of drugs to the skin
Abstract:A method of increasing the adhesiveness of a shaped pressure sensitive adhesive, comprising adding an adhesiveness and drug release increasing amount of a clay to said adhesive prior to casting of the adhesive. A dermal composition comprising a drug, a pressure sensitive adhesive, an adhesiveness increasing amount of a clay and a solvent. A dermal composition comprising a drug, a multipolymer of ethylene vinyl acetate, an acrylic polymer, a natural or synthetic rubber and a clay, along with optional ingredients known for use in transdermal drug delivery systems.
Inventor(s): Sablotsky; Steven (Miami, FL), Gentile; Joseph A. (Plantation, FL)
Assignee: Noven Pharmaceuticals, Inc. (Miami, FL)
Application Number:07/671,709
Patent Claim Types:
see list of patent claims
Use; Composition;

No matches for this query

International Patent Family for Patent: 5,300,291

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ireland64436► Subscribe
Ireland900090► Subscribe
Ireland69048► Subscribe
Ireland940503► Subscribe
Israel102277► Subscribe
Israel112269► Subscribe
JapanH03503283► Subscribe
Japan2659837► Subscribe
JapanH04504515► Subscribe
Japan2724043► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Teva
McKinsey
Baxter
Cerilliant
Harvard Business School
Johnson and Johnson
Medtronic
Fish and Richardson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot